Kyoto, Japan

Mamoru Inoue

This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mamoru Inoue. Retrieved from https://idiyas.com/inventor/mamoru-inoue-f2ag1fm3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mamoru Inoue: Innovator in Anti-Inflammatory Research

Introduction

Mamoru Inoue is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. His innovative work has led to the creation of valuable patents that enhance medical treatments.

Latest Patents

Inoue holds a patent for "Phenylamidinothiophene derivatives and anti-inflammatory agent." This patent represents a crucial advancement in the search for effective treatments for inflammation-related conditions. His research has the potential to improve the quality of life for many patients suffering from such ailments.

Career Highlights

Mamoru Inoue is currently employed at Kaken Pharmaceutical Company, Ltd. His role at the company allows him to engage in cutting-edge research and development. With a focus on innovative solutions, Inoue has established himself as a key figure in the pharmaceutical industry.

Collaborations

Inoue has collaborated with notable coworkers, including Kiyomi Tanaka and Tokiko Nishida. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Mamoru Inoue's contributions to the field of anti-inflammatory research exemplify the importance of innovation in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…